Blog
Big Molecule Watch
November 3, 2020
Election Day in the US
In observance of Election Day, Goodwin’s US offices are closed on Tuesday, November 3. We encourage everyone in our community to do their civic duty and vote. The BMW blog will be back on Wednesday, November 4.
The post Election Day in the US appeared first on Big Molecule Watch.
Related Content
- Big Molecule WatchNovember 20, 2026
Redacted Opinion Filed in Golimumab Preliminary Injunction Case
- Big Molecule WatchNovember 19, 2026
USPTO Institutes Amneal and Kashiv IPR on Omalizumab Patent
- Big Molecule WatchNovember 9, 2026
Teva and Samsung Bioepis Enter Into Licensing Agreement to Commercialize Etanercept and Infliximab Biosimilars in the U.S.
- Big Molecule WatchNovember 9, 2026
Fresenius and WuXi Biologics Enter Development Agreement
- Big Molecule WatchNovember 6, 2026
Theriva Biologics Sells Antibiotic-Degrading Enzyme Portfolio to Biossil Labs
- Big Molecule WatchNovember 6, 2026
Adalvo Expands Biosimilars Portfolio Through Acquisition of Romiplostim Biosimilar Program from Enzene
- Big Molecule WatchNovember 6, 2026
FDA Approves Xbrane’s LUCAMZI™, a Biosimilar to LUCENTIS®
- Big Molecule WatchNovember 3, 2026
Global Biosimilar Market Update: Secukinumab Biosimilar Approval in China and Expanded Ustekinumab Licensing Rights
- Press ReleaseNovember 9, 2026
Goodwin Wins High-Stakes Life Sciences Patent Trial for United Therapeutics Corporation
- Market RecognitionOctober 3, 2025
Goodwin Named an LMG Life Sciences Life Cycle Firm for the Fourteenth Consecutive Year
- Market RecognitionSeptember 9, 2024
Goodwin Named Venture Capital Firm of the Year, Hatch-Waxman Litigation Firm of the Year and Life Cycle Firm of the Year at the 2024 LMG Life Sciences Americas Awards
- Market RecognitionSeptember 25, 2023
Goodwin Named an LMG Life Sciences Life Cycle Firm for the Twelfth Consecutive Year
- Market RecognitionOctober 4, 2022
LMG Recognizes Goodwin Lawyers and Practices for Excellence in Life Sciences
- Press ReleaseNovember 17, 2021
Goodwin Releases Update to its Comprehensive Guide to Biosimilars Litigation and Regulation in the U.S.
- Market RecognitionOctober 26, 2021
Goodwin Named an LMG Life Sciences Life Cycle Firm for the Tenth Consecutive Year
- Press ReleaseJune 28, 2021
Goodwin Adds Life Sciences and Healthcare Litigation Partner William Jackson